Virginia Borges, University of Colorado Denver (IMAGE)

University of Colorado Anschutz Medical Campus

Virginia Borges, University of Colorado Denver

Caption

At ASCO 2015, Virginia Borges, M.D., M.M.Sc., and colleagues report promising clinical trial results of ONT-380 against HER2+ breast cancer.

Credit

University of Colorado Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.